Fecal Elastase: A Complete Medical Overview

Fecal elastase is an enzyme measured in a stool sample to assess whether the pancreas is making enough digestive enzymes. A low result can suggest exocrine pancreatic insufficiency, but it should be interpreted alongside symptoms, stool consistency and other medical findings.

What is fecal elastase?

Fecal elastase is a digestive enzyme made by the pancreas. The pancreas releases enzymes into the small intestine after meals, where they help break down fats, proteins and carbohydrates. Elastase remains relatively stable as it passes through the digestive tract, which makes it possible to measure in a stool sample.

The fecal elastase test is most often used to help evaluate exocrine pancreatic insufficiency (EPI). EPI occurs when the pancreas does not release enough digestive enzymes for normal digestion and nutrient absorption. The test is simple, noninvasive and commonly used as an initial assessment when pancreatic enzyme deficiency is suspected.

A fecal elastase result is useful information, but it is not a diagnosis by itself. A clinician considers the result together with a person’s symptoms, medical history, nutrition, other laboratory tests and, when needed, imaging of the pancreas or digestive system.

Why a fecal elastase test may be requested

A healthcare professional may request a fecal elastase test when someone has symptoms that could reflect poor digestion or reduced absorption of nutrients. The test is particularly helpful when there is concern that pancreatic enzyme production may be lower than expected.

Symptoms that may prompt testing include frequent loose stools, stools that are pale, oily or difficult to flush, excess gas, abdominal bloating, unexplained weight loss, or difficulty maintaining weight. Some people may also develop vitamin and mineral deficiencies, especially deficiencies of fat-soluble vitamins such as vitamins A, D, E and K.

The test may also be considered in people with conditions associated with a higher likelihood of EPI. These can include chronic pancreatitis, cystic fibrosis, pancreatic surgery, pancreatic cancer, long-standing diabetes, celiac disease, inflammatory bowel disease, or certain gastrointestinal operations. Having one of these conditions does not necessarily mean a person has EPI, but it may guide appropriate evaluation.

How the fecal elastase test is performed

The test requires a small stool sample collected at home or in a healthcare setting and sent to a laboratory. It does not require a blood draw, endoscopy or fasting in most situations. The laboratory measures the concentration of pancreatic elastase in the sample, usually reported as micrograms per gram of stool.

For the most reliable result, the sample should be formed or semi-formed when possible. Very watery diarrhea can dilute the enzyme concentration in the sample and may lead to a falsely low reading. If a result is low but the sample was watery, a clinician may recommend repeating the test with a more solid sample or using other assessments.

Pancreatic enzyme replacement therapy generally does not need to be stopped before fecal elastase testing because standard enzyme products do not interfere with the assay. However, people should always follow the instructions provided by their own clinician and laboratory, particularly if they take multiple medicines or have recently had digestive testing.

Understanding fecal elastase results

Although reference ranges can vary slightly by laboratory, a fecal elastase level above 200 micrograms per gram of stool is generally considered consistent with adequate pancreatic exocrine function. Results between 100 and 200 micrograms per gram may be considered borderline or suggestive of mild to moderate pancreatic enzyme insufficiency. Levels below 100 micrograms per gram more strongly support significant EPI.

A low result does not always mean the pancreas is permanently damaged. Diarrhea-related dilution, sample handling issues and some non-pancreatic digestive conditions can affect the result. Conversely, a normal result makes moderate to severe EPI less likely, but it may not fully exclude mild disease when symptoms and clinical suspicion remain strong.

Healthcare professionals may repeat the test, review diet and symptoms, check nutritional markers, or request additional investigations when appropriate. These may include blood tests, imaging such as ultrasound, CT or MRI, or specialized tests that evaluate digestion and absorption. The right next step depends on the individual situation.

• More than 200: usually normal pancreatic enzyme output.
• 100 to 200: may be indeterminate or consistent with reduced enzyme output; clinical context is important.
• Less than 100: more suggestive of significant exocrine pancreatic insufficiency.

What can cause low fecal elastase?

Low fecal elastase can occur when pancreatic enzyme production is reduced. Chronic pancreatitis is an important cause because long-term inflammation can damage enzyme-producing pancreatic tissue. Other possible causes include pancreatic duct blockage, pancreatic surgery, removal of part of the pancreas, cystic fibrosis and pancreatic tumors.

Reduced pancreatic function may also occur in some people with diabetes, particularly long-standing diabetes, and in people with certain digestive diseases. Celiac disease, Crohn’s disease and prior gastrointestinal surgery may be associated with symptoms or test findings that overlap with EPI. In these situations, a thorough assessment helps distinguish pancreatic insufficiency from other causes of malabsorption or diarrhea.

It is also important to recognize that a low reading may be temporary or misleading when stool is very loose or watery. Therefore, clinicians do not usually make major treatment decisions from one laboratory result alone. They evaluate whether the result fits the person’s symptoms, nutritional status and overall medical history.

Treatment and everyday management

Treatment focuses on the cause of low fecal elastase and on improving digestion and nutrition when EPI is confirmed. For many people with clinically significant EPI, clinicians may prescribe pancreatic enzyme replacement therapy. These prescription enzymes are taken with meals and snacks to help the body digest food more effectively.

Nutritional support can also be important. A clinician or registered dietitian may assess weight trends, protein intake and levels of vitamins and minerals. People with fat malabsorption may need monitoring for fat-soluble vitamin deficiencies and bone health. Restrictive diets should not be started without professional guidance, since unnecessary fat restriction can contribute to weight loss or poor nutrition.

Avoiding smoking and limiting or avoiding alcohol may be particularly important for people with pancreatic disease, depending on the underlying condition and personal medical advice. Ongoing follow-up helps ensure symptoms are improving and allows the care team to adjust treatment if needed.

Acibadem International’s multidisciplinary specialists and JCI-accredited hospitals evaluate pancreatic and digestive concerns for international patients, using individualized assessment and follow-up when clinically appropriate.

When to seek medical care

A person should arrange a medical assessment if they have persistent diarrhea, recurring greasy or floating stools, ongoing abdominal discomfort, unexplained weight loss, loss of appetite, or fatigue that may be related to poor nutrient absorption. These symptoms can have many causes, and timely evaluation can help clarify what is happening.

More urgent medical attention is appropriate for severe or worsening abdominal pain, repeated vomiting, inability to keep fluids down, yellowing of the skin or eyes, black or bloody stools, fainting, or signs of dehydration. These symptoms do not specifically indicate pancreatic insufficiency, but they require prompt assessment.

People who receive a low fecal elastase result should discuss it with the clinician who ordered the test rather than trying over-the-counter digestive supplements on their own. A qualified professional can determine whether repeat testing, further investigation, nutritional support or prescription treatment is needed.

Frequently asked questions

What does a fecal elastase test measure?

A fecal elastase test measures the amount of pancreatic elastase in a stool sample. It helps assess whether the pancreas is producing enough digestive enzymes, especially enzymes needed for normal digestion and absorption of nutrients.

What is considered a normal fecal elastase level?

In many laboratories, a result above 200 micrograms per gram of stool is considered normal. Reference ranges can differ, so the laboratory report and the clinician’s interpretation should always be used when reviewing a result.

Can watery diarrhea cause low fecal elastase?

Yes. A very watery stool sample can dilute elastase and produce a falsely low result. If this is suspected, a clinician may recommend repeating the test using a formed or semi-formed stool sample when possible.

Does a low fecal elastase result always mean pancreatic disease?

No. A low result can suggest exocrine pancreatic insufficiency, but it does not confirm the cause by itself. Stool consistency, symptoms, medical history and further tests may all be needed to determine whether pancreatic disease or another issue is present.

Should pancreatic enzyme medicines be stopped before the test?

Standard pancreatic enzyme replacement medicines usually do not interfere with fecal elastase testing because the test measures human pancreatic elastase. However, a person should follow the instructions from their own healthcare professional or laboratory.

What symptoms may occur with exocrine pancreatic insufficiency?

Possible symptoms include frequent loose stools, oily or foul-smelling stools, bloating, gas, weight loss and difficulty maintaining weight. Some people develop nutritional deficiencies because fats and other nutrients are not being absorbed well.

References

• National Institute of Diabetes and Digestive and Kidney Diseases
• American College of Gastroenterology
• National Pancreas Foundation
• Cystic Fibrosis Foundation
• Mayo Clinic

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.